NasdaqGS - Delayed Quote USD

Canopy Growth Corporation (CGC)

Compare
4.5800 +0.1600 (+3.62%)
At close: 4:00 PM EDT
4.5710 -0.01 (-0.20%)
After hours: 5:40 PM EDT
Loading Chart for CGC
DELL
  • Previous Close 4.4200
  • Open 4.4000
  • Bid 4.5700 x 900
  • Ask 4.6000 x 1100
  • Day's Range 4.3700 - 4.6100
  • 52 Week Range 2.7550 - 14.9200
  • Volume 5,867,637
  • Avg. Volume 3,542,688
  • Market Cap (intraday) 510.162M
  • Beta (5Y Monthly) 1.79
  • PE Ratio (TTM) --
  • EPS (TTM) -5.8500
  • Earnings Date Nov 12, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.11

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

www.canopygrowth.com

1,029

Full Time Employees

March 31

Fiscal Year Ends

Recent News: CGC

View More

Performance Overview: CGC

Trailing total returns as of 10/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CGC
10.37%
S&P/TSX Composite index
14.36%

1-Year Return

CGC
37.86%
S&P/TSX Composite index
24.98%

3-Year Return

CGC
96.58%
S&P/TSX Composite index
18.95%

5-Year Return

CGC
97.92%
S&P/TSX Composite index
46.95%

Compare To: CGC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CGC

View More

Valuation Measures

Annual
As of 10/2/2024
  • Market Cap

    375.16M

  • Enterprise Value

    692.04M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.68

  • Price/Book (mrq)

    0.95

  • Enterprise Value/Revenue

    3.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -259.94%

  • Return on Assets (ttm)

    -3.83%

  • Return on Equity (ttm)

    -87.26%

  • Revenue (ttm)

    287.1M

  • Net Income Avi to Common (ttm)

    -602.3M

  • Diluted EPS (ttm)

    -5.8500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    196.92M

  • Total Debt/Equity (mrq)

    117.00%

  • Levered Free Cash Flow (ttm)

    17.19M

Research Analysis: CGC

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 66.21M
Earnings -127.14M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

2.00 Low
4.11 Average
4.5800 Current
5.88 High
 

Company Insights: CGC

Research Reports: CGC

View More
  • Canopy Growth: CEO David Klein to Retire; Search for Replacement Has Begun

    Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

    Rating
    Price Target
     
  • Canopy Earnings: Shares Look Fairly Valued as Cannabis Positions Are Middling

    Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

    Rating
    Price Target
     
  • US Deals Help Unlock Some Value but Doesn't Help Canopy Growth's Lagging Canadian Operations

    Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

    Rating
    Price Target
     
  • Canopy Earnings: Losses Narrow and Near-Term Dilution Risk Falls, but Shares Fairly Valued

    Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

    Rating
    Price Target
     

People Also Watch